Al Hammadi Company for Development and Investment Announces the Completion of the Construction Works in Al Hammadi Hospital Al Nuzha Branch
Al Hammadi Company for Development and Investment announces the completion of the construction work in Al Hammadi Hospital Al Nuzha branch and commencing the test run starting from 13 March 2017 by operating the medical and electromechanical equipment for testing and calibrating purpose and continue working on completing the required medical and administrative staff for commercial run. The total project cost is SR 823 million including the land cost. The Company will announce the commencement of the commercial run later after obtaining all required licenses from the concerned parties. It is worth mentioning that Al Hammadi Hospital Al Nuzha branch was built based on the recent architectural and engineering designs and equipped with latest medical equipment. The hospital built on a land parcel of 21,809 sqm at Al Nuzha district in the northeast Riyadh city. The building has six floors and two underground floors in addition to multi floors parking expands for more than 800 car. The built up area is 101,000 sqm. The hospital capacity reaches 650 beds including 75 critical care beds and 320 long stay and re-habitation beds in addition to 64-outpatient clinic. This project after the commercial run should be a distinguished medical monument and main supporter to the Company future growth as the full capacity of the Company three hospitals will reach 1,378 beds and 202-outpatient clinic.
The Capital Market Authority and the Saudi Stock Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.